Sign in
8-K

Current Report

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-385331

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading d160615d8k.htm…